Healthcare · Diagnostics & Research · NASDAQ

GRAIL LLC (GRAL) Stock Price, Analysis & Trade Signals

$99.25-5.59 (-5.33%)

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted…

GRAL key stats

Market Cap
$4.46B
P/E Ratio
0
Forward P/E
0.98
EPS
-9.22
52 Week Range
$41.50 – $166.48
50-Day Avg
123.32
200-Day Avg
79.27
Revenue (TTM)
$166.6M
Revenue Growth (Qtr YoY)
3.7%
Profit Margin
-244%
Operating Margin (TTM)
-332%
Beta
2.87
Volume
758K
30-Day Avg Volume
880.55K
Next Earnings
Feb 18, 2027
Estimated EPS
-2.38
CEO
Joshua J. Ofman
Employees
910
IPO Date
Jun 12, 2024

GRAL on X: what traders are saying

  • Danny Naz @ThePupOfWallSt · Nov 3, 2026

    $GRAL nice hold of the trendline, inside day setting up. https://t.co/p3fC4ZFK2a https://t.co/7WeUdbJk5X

  • Danny Naz @ThePupOfWallSt · Nov 1, 2026

    $GRAL | Bull Pennant Continuation Really nice-looking chart. We had that breakaway gap, a controlled pullback into the 10/21 EMA cloud, and then a strong move higher. Now we're pulling back toward the cloud and rising trendline again. I'd like to see buyers defend this area…

  • Danny Naz @ThePupOfWallSt · Nov 1, 2026

    Dropping 25 chart book updates for subs $AMD , $GDYN , $GEN , $GRAL, $HUBS, $IBM, $LIFE, $LLY, $LTH, $MRNA, $OXY, $PLTR, $PURR, $RBRK, $SN, $SPOT, $STNG, $TEM, $TENB, $TSLA, $ULTA, $UNH, $VG, $WDAY, $YOU https://t.co/Akfm2BWzrV

  • Danny Naz @ThePupOfWallSt · Oct 27, 2026

    Jesus took the wheel $GRAL https://t.co/KsrC7TBmrN https://t.co/4v4P2qhmaW

  • Danny Naz @ThePupOfWallSt · Oct 26, 2026

    $GRAL on the move again https://t.co/9MKFCVzCWQ https://t.co/FI0rXaawpd

GRAL analyst rating & price target

10 analysts rate GRAL Buy on consensus.

0Strong Buy
5Buy
5Hold
0Sell
0Strong Sell

Consensus price target: $139.44 (+40.49% upside from $99.25)

Recent GRAL insider transactions

InsiderDateTransactionSharesValue
Freidin Aaron
Chief Financial Officer
Nov 16, 2026Sale300$31.83K
Freidin Aaron
Chief Financial Officer
Nov 16, 2026Sale100$11.25K
Freidin Aaron
Chief Financial Officer
Nov 16, 2026Sale500$54.42K
Freidin Aaron
Chief Financial Officer
Nov 16, 2026Sale1,200$128.94K
Freidin Aaron
Chief Financial Officer
Nov 16, 2026Sale500$52.48K

GRAIL LLC annual revenue & net income

Fiscal yearRevenueRevenue YoYNet income
2025$147.17M+17.18%$-408.35M
2024$125.6M+34.9%$-2.03B
2023$93.11M+67.61%$-1.47B

Latest GRAL news

Stock data for GRAL: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics